Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd (688336.SS)
CNY 21.63
(-0.18%)
CNY 21.63
(-0.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 194.95 Million CNY | -14.12% |
| 2022 | 227 Million CNY | 8.02% |
| 2021 | 210.14 Million CNY | -6.64% |
| 2020 | 225.07 Million CNY | 33.8% |
| 2019 | 168.21 Million CNY | 32.18% |
| 2018 | 127.26 Million CNY | 17.05% |
| 2017 | 108.72 Million CNY | -5.65% |
| 2016 | 115.23 Million CNY | 12.35% |
| 2015 | 102.56 Million CNY | 5.02% |
| 2014 | 97.66 Million CNY | 11.57% |
| 2013 | 87.53 Million CNY | 35.3% |
| 2012 | 64.69 Million CNY | 64.36% |
| 2011 | 39.36 Million CNY | 14.39% |
| 2010 | 34.41 Million CNY | -6.54% |
| 2009 | 36.81 Million CNY | 9.16% |
| 2008 | 33.73 Million CNY | 8.99% |
| 2007 | 30.94 Million CNY | 82.73% |
| 2006 | 16.93 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q3 | 203.54 Million CNY | 8.03% |
| 2024 Q1 | 218.97 Million CNY | 12.32% |
| 2024 Q2 | 188.41 Million CNY | -13.95% |
| 2023 Q1 | 197.42 Million CNY | -13.03% |
| 2023 FY | 194.95 Million CNY | -14.12% |
| 2023 Q4 | 194.95 Million CNY | 7.91% |
| 2023 Q3 | 180.66 Million CNY | -1.1% |
| 2023 Q2 | 182.67 Million CNY | -7.47% |
| 2022 Q1 | 227.79 Million CNY | 8.4% |
| 2022 Q2 | 231.38 Million CNY | 1.58% |
| 2022 Q4 | 227 Million CNY | -8.04% |
| 2022 Q3 | 246.85 Million CNY | 6.69% |
| 2022 FY | 227 Million CNY | 8.02% |
| 2021 Q2 | 225.21 Million CNY | -9.95% |
| 2021 Q1 | 250.09 Million CNY | 11.12% |
| 2021 Q3 | 245.76 Million CNY | 9.13% |
| 2021 Q4 | 210.14 Million CNY | -14.5% |
| 2021 FY | 210.14 Million CNY | -6.64% |
| 2020 Q4 | 225.07 Million CNY | 17.16% |
| 2020 Q3 | 192.11 Million CNY | 10.93% |
| 2020 Q2 | 173.18 Million CNY | -6.92% |
| 2020 Q1 | 186.04 Million CNY | 10.6% |
| 2020 FY | 225.07 Million CNY | 33.8% |
| 2019 Q2 | 140.31 Million CNY | 0.0% |
| 2019 FY | 168.21 Million CNY | 32.18% |
| 2019 Q4 | 168.21 Million CNY | 0.0% |
| 2019 Q1 | - CNY | 0.0% |
| 2018 FY | 127.26 Million CNY | 17.05% |
| 2017 FY | 108.72 Million CNY | -5.65% |
| 2016 FY | 115.23 Million CNY | 12.35% |
| 2015 FY | 102.56 Million CNY | 5.02% |
| 2014 FY | 97.66 Million CNY | 11.57% |
| 2013 Q1 | 69.38 Million CNY | 7.24% |
| 2013 Q3 | 80.91 Million CNY | 6.3% |
| 2013 FY | 87.53 Million CNY | 35.3% |
| 2013 Q2 | 76.12 Million CNY | 9.71% |
| 2012 Q3 | 56.88 Million CNY | 0.0% |
| 2012 Q1 | 43.72 Million CNY | 11.08% |
| 2012 Q4 | 64.69 Million CNY | 13.74% |
| 2012 FY | 64.69 Million CNY | 64.36% |
| 2011 Q2 | 32.88 Million CNY | -3.66% |
| 2011 FY | 39.36 Million CNY | 14.39% |
| 2011 Q4 | 39.36 Million CNY | 30.36% |
| 2011 Q3 | 30.19 Million CNY | -8.17% |
| 2011 Q1 | 34.13 Million CNY | -0.82% |
| 2010 Q4 | 34.41 Million CNY | -16.09% |
| 2010 FY | 34.41 Million CNY | -6.54% |
| 2010 Q3 | 41 Million CNY | 0.0% |
| 2009 FY | 36.81 Million CNY | 9.16% |
| 2008 FY | 33.73 Million CNY | 8.99% |
| 2007 FY | 30.94 Million CNY | 82.73% |
| 2006 FY | 16.93 Million CNY | 0.0% |